FZAHX
Price
$186.72
Change
+$1.85 (+1.00%)
Updated
May 8 closing price
Net Assets
22.34B
RGABX
Price
$64.63
Change
+$0.47 (+0.73%)
Updated
May 8 closing price
Net Assets
283.8B
Ad is loading...

FZAHX vs RGABX

Header iconFZAHX vs RGABX Comparison
Open Charts FZAHX vs RGABXBanner chart's image
Fidelity Advisor Growth Opps Z
Price$186.72
Change+$1.85 (+1.00%)
VolumeN/A
Net Assets22.34B
American Funds Growth Fund of Amer R2
Price$64.63
Change+$0.47 (+0.73%)
VolumeN/A
Net Assets283.8B
FZAHX vs RGABX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FZAHX vs. RGABX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FZAHX is a Buy and RGABX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGABX has more cash in the bank: 284B vs. FZAHX (22.3B). FZAHX (0.00) and RGABX (0.00) have matching dividends . FZAHX was incepted earlier than RGABX: FZAHX (12 years) vs RGABX (23 years). RGABX (1.39) is less costly to investors than FZAHX (0.37). FZAHX is a more actively managed with annual turnover of: 56.00 vs. RGABX (25.00). FZAHX has a lower initial minimum investment than RGABX: FZAHX (0) vs RGABX (250). FZAHX annual gain was more profitable for investors over the last year : 11.91 vs. RGABX (1.96). FZAHX return over 5 years is better than : 78.15 vs. RGABX (36.12).
FZAHXRGABXFZAHX / RGABX
Total Expense Ratio0.371.3927%
Annual Report Gross Expense Ratio0.371.3927%
Fund Existence12 years23 years-
Gain YTD-8.025-2.695298%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets22.3B284B8%
Annual Yield % from dividends0.000.00-
Returns for 1 year11.911.96609%
Returns for 3 years71.4529.21245%
Returns for 5 years78.1536.12216%
Returns for 10 years166.0448.37343%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACAD16.932.39
+16.44%
ACADIA Pharmaceuticals
XP17.591.75
+11.05%
XP
ACRS1.310.06
+4.80%
Aclaris Therapeutics
DAKT13.950.31
+2.27%
Daktronics
NLSP1.65-0.05
-2.94%
Nls Pharmaceutics Ltd